NCT01533207 · OUTCOME

Univariate and Multi-variable Prognostic Significance of Baseline Clinical, Pathologic, or Demographic Factors

Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery · Source last updated 2020-04-28

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Up to 5 years

What was measured

Analyses will be carried out using proportional hazards models of both survival and recurrence.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Analyses will be carried out using proportional hazards models of both survival and recurrence.
reporting Status: NOT_POSTED
time Frame: Up to 5 years
title: Univariate and Multi-variable Prognostic Significance of Baseline Clinical, Pathologic, or Demographic Factors
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice